Sanara Medtech Inc (SMTI) Stock Price, Quote & News

Company Profile

Sanara MedTech Inc., a medical technology company, develops, markets, and distributes surgical, wound, and skincare products and services to physicians, hospitals, clinics, and post-acute care settings in the United States. The company offers CellerateRX Surgical, a medical hydrolysate of Type I bovine collagen indicated for the management of surgical, traumatic, and partial- and full-thickness wounds, as well as first- and second-degree burns. It also develops BIASURGE, a no-rinse surgical solu...

Industry: Medical Instruments & Supplies

Sector: Healthcare

Phone: 817 529 2300

Website: sanaramedtech.com

Address:

1200 Summit Avenue, Suite 414, Fort Worth, United States

TheRiskyInvestor Mar. 13 at 4:54 PM

Stocks on my watchlist: $MELI $SMTI (low float very high RR) $SOFI $CACC $AMTM (would be an add and would be averging well up from average if bought. Also IF any of my current holdings fell or presented good opportunity I would be more than happy to average up on plays!

0 · Reply

PsychoPass Mar. 12 at 6:53 PM

$SMTI started again 18.96$

0 · Reply

StockNews_Live Mar. 11 at 11:32 AM

$SMTI 🎯 STOCK NEWS ALERT 💵 Price: $19.69 (-5.06%) 🔥 Sentiment Score: 85/100 🚀 VERY POSITIVE NEWS 📄 Sanara MedTech Inc. announced the publication of a peer-reviewed study evaluating the economic and clinical value of CellerateRX Surgical Powder in the Journal of Medical Economics. The study… 📎 https://stocknews.live/news/SMTI/sanara-med-tech-inc-91317.html

0 · Reply

TheTradeXchange Mar. 11 at 11:30 AM

$SMTI - Sanara MedTech Inc. Announces Publication of Peer-Reviewed Study Evaluating the Economic and Clinical Value of CellerateRX® Surgical Powder in the Management of Spine Surgery Wounds

0 · Reply

PsychoPass Mar. 10 at 4:47 AM

$SMTI sold at 20,30$

0 · Reply

PsychoPass Mar. 5 at 7:12 PM

$SMTI started position

0 · Reply

BillionerOfKing Mar. 3 at 1:44 AM

$SMTI Current Stock Price: $20.36

0 · Reply

ksoth12 Feb. 26 at 5:54 PM

$SMTI One thing everyone seems to be missing with this company is without THP cash drain this company should be extremely profitable in 2026 and going forward. Their sales costs are under control and revenues are growing with 92% gross margins. This company should print some serious EPS numbers in 2026 and going forward. Last release in the 10q they gave THP cost breakdowns which allow anyone to estimate results going forward factoring out THP costs. This doesn’t seem to be priced into the stock price as everyone is fixated on the q4 comparison thinking growth is slowing to a crawl. It’s not. They just had an abnormally strong q4 2024 due to one time events leading to a difficult yoy comparison. Once past that we should start looking to 2026. It will be interesting to see how the next eps release goes.

0 · Reply

OfficialStocktwitsUser Feb. 25 at 11:37 PM

$SMTI RSI: 41.36, MACD: -0.6393 Vol: 0.87, MA20: 20.25, MA50: 22.33 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

MyrtleLockwood880 Feb. 21 at 8:41 AM

$SMTI Sanara MedTech develops wound care products. Revenue growth depends on adoption. Margins improve with scale.

0 · Reply

Sanara MedTech Inc. Announces Publication of Peer-Reviewed Study Evaluating the Economic and Clinical Value of CellerateRX® Surgical Powder in the Management of Spine Surgery Wounds

Mar 3, 2026, 7:30 AM EST - 13 days ago

Sanara MedTech Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on March 24, 2026

Feb 17, 2026, 7:30 AM EST - 27 days ago

Sanara MedTech Inc. to Participate in the TD Cowen 46th Annual Health Care Conference on March 3rd

Jan 23, 2026, 7:30 AM EST - 7 weeks ago

Sanara MedTech Inc. Reports Unaudited Preliminary Financial Results for the Fourth Quarter and Full Year 2025; Introduces Full Year 2026 Financial Guidance

Jan 7, 2026, 4:05 PM EST - 2 months ago

Sanara MedTech Inc. Receives Innovative Technology Contract from Vizient for BIASURGE® Advanced Surgical Solution

Dec 10, 2025, 8:37 AM EST - 3 months ago

Sanara MedTech Inc. and Biomimetic Innovations Provide Update on OsStic™

Nov 27, 2025, 7:41 AM EST - 3 months ago

Sanara MedTech: Too Cheap And Better Positioned After Earlier Strategic Missteps

Nov 19, 2025, 7:30 AM EST - 4 months ago

Sanara MedTech to Participate in the Piper Sandler 37th Annual Healthcare Conference on December 3rd

Nov 12, 2025, 10:01 AM EST - 4 months ago

Sanara MedTech Inc. (SMTI) Q3 2025 Earnings Call Transcript

Nov 12, 2025, 7:00 AM EST - 4 months ago

Sanara MedTech Inc. Reports Third Quarter 2025 Financial Results (Unaudited)

Nov 11, 2025, 4:05 PM EST - 4 months ago

Sanara MedTech Inc. Announces Strategic Realignment to Focus on Surgical Business

Oct 1, 2025, 7:30 AM EDT - 5 months ago

Sanara MedTech to Report Third Quarter 2025 Financial Results on November 12, 2025

Sep 4, 2025, 2:46 PM EDT - 6 months ago

Sanara MedTech: Growth Remains Strong As Debt Concerns Recede

Sep 2, 2025, 4:30 PM EDT - 6 months ago

Sanara MedTech Inc. Announces Chief Executive Officer Transition

Aug 27, 2025, 4:05 PM EDT - 7 months ago

Sanara MedTech Inc. to Present at the Cantor Global Healthcare Conference on September 3, 2025

Aug 13, 2025, 12:18 PM EDT - 7 months ago

Sanara MedTech Inc. (SMTI) Q2 2025 Earnings Call Transcript

Aug 13, 2025, 7:00 AM EDT - 7 months ago

Sanara MedTech Inc. Reports Second Quarter 2025 Financial Results (Unaudited)

Jul 15, 2025, 4:05 PM EDT - 8 months ago

Sanara MedTech to Report Second Quarter 2025 Financial Results on August 13, 2025

Jul 14, 2025, 4:05 PM EDT - 8 months ago

Sanara MedTech Inc. Announces Launch of Tissue Health Plus Wound Care Provider Pilot Program

Jun 9, 2025, 6:22 AM EDT - 10 months ago

Sanara MedTech: Pursuing Rapid Expansion While Debt Levels Climb

May 14, 2025, 11:55 AM EDT - 10 months ago

Sanara MedTech Inc. (SMTI) Q1 2025 Earnings Call Transcript

May 14, 2025, 7:00 AM EDT - 10 months ago

Sanara MedTech Inc. Reports First Quarter 2025 Financial Results (Unaudited)

Apr 23, 2025, 8:00 AM EDT - 11 months ago

Sanara MedTech to Report First Quarter 2025 Financial Results on May 14, 2025

Apr 10, 2025, 4:00 PM EDT - 1 year ago

Sanara MedTech to Present at the Planet MicroCap Showcase: VEGAS 2025 on April 23, 2025

Mar 25, 2025, 9:15 AM EDT - 1 year ago

Sanara MedTech Inc. (SMTI) Q4 2024 Earnings Call Transcript

Mar 25, 2025, 7:00 AM EDT - 1 year ago

Sanara MedTech Inc. Reports Fourth Quarter and Full Year 2024 Financial Results (Unaudited)

Mar 11, 2025, 4:05 PM EDT - 1 year ago

Sanara MedTech to Report Fourth Quarter and Full Year 2024 Financial Results on March 25, 2025

Jan 30, 2025, 12:28 PM EST - 1 year ago

Sanara MedTech: A Promising Growth Story At An Attractive Valuation

Jan 24, 2025, 7:00 AM EST - 1 year ago

Biomimetic Innovations Ltd, an affiliate of PBC Biomed, Announces an Exclusive License and Distribution Agreement and Minority Investment with Sanara MedTech Inc.

Jan 21, 2025, 4:10 PM EST - 1 year ago

Sanara MedTech Inc. Announces Exclusive License and Distribution Agreement with, and Minority Investment in, Biomimetic Innovations Ltd

Jan 21, 2025, 4:08 PM EST - 1 year ago

Sanara MedTech Inc. Expands Executive Leadership Team with New Appointments

Jan 21, 2025, 4:05 PM EST - 1 year ago

Sanara MedTech Inc. Reports Unaudited Preliminary Results for the Fourth Quarter and Full Year 2024

Nov 25, 2024, 4:05 PM EST - 1 year ago

Sanara MedTech to Present at the Piper Sandler 36th Annual Healthcare Conference on December 4th

Nov 13, 2024, 2:47 PM EST - 1 year ago

Sanara MedTech Inc. (SMTI) Q3 2024 Earnings Call Transcript

Nov 12, 2024, 4:15 PM EST - 1 year ago

Sanara MedTech Inc. Reports Third Quarter 2024 Results

Oct 31, 2024, 9:15 AM EDT - 1 year ago

Sanara MedTech Inc. Announces Third Quarter Earnings Release and Conference Call Dates

Oct 7, 2024, 9:15 AM EDT - 1 year ago

Sanara MedTech Inc. Announces Changes to Its Board of Directors

Oct 2, 2024, 12:04 PM EDT - 1 year ago

Sanara MedTech Inc (SMTI) Trading 3.79% Higher on Oct 2

Sep 11, 2024, 6:30 AM EDT - 1 year ago

Sanara MedTech Inc. and InfuSystem Holdings, Inc. Announce Exclusive United States Distribution Agreement with, and Minority Investment in, ChemoMouthpiece, LLC

Aug 13, 2024, 12:09 PM EDT - 1 year ago

Sanara MedTech Inc. (SMTI) Q2 2024 Earnings Call Transcript

Aug 12, 2024, 4:15 PM EDT - 1 year ago

Sanara MedTech Inc. Announces Second Quarter 2024 Results

Jul 30, 2024, 9:15 AM EDT - 1 year ago

Sanara MedTech Inc. Announces Second Quarter Earnings Release and Conference Call Dates

May 14, 2024, 3:00 PM EDT - 1 year ago

Sanara MedTech Inc. (SMTI) Q1 2024 Earnings Call Transcript

May 13, 2024, 9:15 AM EDT - 2 years ago

Sanara MedTech Inc. Announces First Quarter 2024 Results

Apr 29, 2024, 9:15 AM EDT - 2 years ago

Sanara MedTech Inc. Announces First Quarter Earnings Release and Conference Call Dates

Apr 18, 2024, 9:15 AM EDT - 2 years ago

Sanara MedTech Inc. Announces $55 Million Debt Facility

Apr 5, 2024, 9:00 AM EDT - 2 years ago

Sanara MedTech Inc. Announces the Appointments of Jake Waldrop as Chief Operating Officer and Tyler Palmer as Chief Corporate Development and Strategy Officer

Mar 26, 2024, 10:59 AM EDT - 2 years ago

Sanara MedTech Inc. (SMTI) Q4 2023 Earnings Call Transcript

Mar 25, 2024, 4:05 PM EDT - 2 years ago

Sanara MedTech Inc. Announces Fourth Quarter and Full Year 2023 Results

TheRiskyInvestor Mar. 13 at 4:54 PM

0 · Reply

PsychoPass Mar. 12 at 6:53 PM

$SMTI started again 18.96$

0 · Reply

StockNews_Live Mar. 11 at 11:32 AM

0 · Reply

TheTradeXchange Mar. 11 at 11:30 AM

$SMTI - Sanara MedTech Inc. Announces Publication of Peer-Reviewed Study Evaluating the Economic and Clinical Value of CellerateRX® Surgical Powder in the Management of Spine Surgery Wounds

0 · Reply

PsychoPass Mar. 10 at 4:47 AM

$SMTI sold at 20,30$

0 · Reply

PsychoPass Mar. 5 at 7:12 PM

$SMTI started position

0 · Reply

BillionerOfKing Mar. 3 at 1:44 AM

$SMTI Current Stock Price: $20.36

0 · Reply

ksoth12 Feb. 26 at 5:54 PM

0 · Reply

OfficialStocktwitsUser Feb. 25 at 11:37 PM

0 · Reply

MyrtleLockwood880 Feb. 21 at 8:41 AM

$SMTI Sanara MedTech develops wound care products. Revenue growth depends on adoption. Margins improve with scale.

0 · Reply

brenbto Feb. 17 at 7:41 PM

$SMTI https://youtu.be/iv1q3SlccVI?si=7o_3kg3ebo1v65y-

0 · Reply

NVDAMillionaire Feb. 4 at 3:07 PM

$SMTI Excellent article that nails exactly where SMTI stands right now. So if you want to update your SMTI knowledge or get acquainted with SMTI, this is a must read. https://everyticker.com/quote/SMTI/analysis/sanara-medtech-building-a-dual-engine-growth-story-on-differentiated-technology-smti

1 · Reply

OfficialStocktwitsUser Jan. 26 at 10:54 PM

$SMTI RSI: 37.96, MACD: -0.5428 Vol: 1.06, MA20: 23.41, MA50: 22.67 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

OfficialStocktwitsUser Dec. 29 at 3:58 PM

$SMTI RSI: 61.81, MACD: 0.1856 Vol: 1.69, MA20: 23.49, MA50: 24.76 🟢 BUY - Uptrend + healthy RSI 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.

0 · Reply

FinancialModeling Dec. 25 at 4:06 PM

$SMTI Macro forces may influence direction, yet internal execution remains the decisive factor. Management alignment and prioritization play a larger role from here. Any disconnect between guidance and outcomes will magnify skepticism. Patience is reasonable — but it must be matched by tangible progress.

0 · Reply

SuperGreenToday Dec. 19 at 6:41 PM

$SMTI

0 · Reply

quodo Dec. 15 at 2:25 PM

$SMTI $CMMB $SERA $NTHI Most small caps are still trying to survive 2026. $CAPS is already planning how to compound through it. $100M run-rate reaffirmed. Margins expanding. Execution > speculation.

0 · Reply

nikitatrades Nov. 16 at 12:01 PM

HC Wainwright & Co. Maintains Buy on $SMTI, Lowers Price Target 🚀 ✅ HC Wainwright & Co. reiterated a "Buy" rating for Sanara MedTech (SMTI), signaling continued confidence in its core business. ✅ The firm adjusted its price target for SMTI downward from $54.00 to $36.00. ✅ This price target revision likely reflects the near-term financial impact of discontinuing the Tissue Health Plus (THP) segment, which entails a cash investment in the latter half of 2025. ✅ The strategic decision to exit THP aims to reallocate resources to the higher-potential surgical business, which demonstrated strong revenue growth in Q3. ✅ Analysts anticipate a deceleration in revenue growth for Q4, potentially contributing to the revised price target.

0 · Reply

FlashMcGash Nov. 14 at 2:04 PM

$SMTI Wainwright puts $36 pt on $SMTI

0 · Reply

JarvisFlow Nov. 14 at 1:05 PM

HC Wainwright & Co. has adjusted their stance on Sanara MedTech ( $SMTI ), setting the rating to Buy with a target price of 54 → 36.

0 · Reply

OpenOutcrier Nov. 12 at 12:59 PM

$SMTI (+7.0% pre) Sanara MedTech (NASDAQ: SMTI) to classify THP as discontinued ops, wind-down through 2025 https://ooc.bz/l/84199

1 · Reply

Market Cap	173.42M
Revenue (ttm)	86.67M
Net Income (ttm)	-9.66M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	29.97
Profit Margin	-11.15%
Debt to Equity Ratio	7.34

Volume	57,903
Avg Vol	60,592
Day's Range	N/A - N/A
Shares Out	8.90M
Stochastic %K	35%
Beta	1.04
Analysts	Sell
Price Target	$36.00